Guanfacine used for treating ADHD in children and adolescents increases corneal aberrations at 6 months but does not affect the retina, choroid, refraction, or optic nerve.
IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.